Defunct Company
Total Trials
10
As Lead Sponsor
7
As Collaborator
3
Total Enrollment
13,643
NCT01872702
Targeted Chemo-elimination (TCE) of Malaria
Phase: N/A
Role: Collaborator
Start: Apr 30, 2013
Completion: Jul 31, 2017
NCT03217851
Prevalence Survey of Antimalarial Drug Resistance Markers
Start: Sep 18, 2017
Completion: Dec 24, 2021
NCT03324776
Initiating Mealtime Ultra-Rapid Acting Insulin (Afrezza) in Uncontrolled Type 2 Diabetes Patients
Phase: Phase 3
Role: Lead Sponsor
Start: Oct 16, 2017
Completion: Jun 10, 2020
NCT03269266
Scrub Typhus RDT Study
Start: Dec 4, 2017
Completion: Dec 26, 2019
NCT03578133
Causes of Pneumonia in Yangon
Start: Jul 9, 2018
Completion: Apr 4, 2019
NCT03847870
Rickettsiae in Myanmar
Start: Jun 20, 2019
Completion: Oct 25, 2019
NCT04781426
PrEP Among MSM and TG in Myanmar
Start: Oct 28, 2020
Completion: Aug 31, 2021
NCT03158857
Hepatitis C Treatment Study in Myanmar
Start: Jan 31, 2022
Completion: Jan 31, 2024
NCT04565795
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
Start: Jul 1, 2022
Completion: Sep 30, 2026
NCT04210141
Optimal Dose of Antivenom for Daboia Siamensis Envenomings
Phase: Phase 2
Start: Apr 30, 2025
Completion: Nov 1, 2027